European society of cardiology (ESC) annual congress report from Barcelona 2017

Kimio Satoh, Jun Takahashi, Yasuharu Matsumoto, Shunsuke Tatebe, Tatsuo Aoki, Yoku Kikuchi, Kiyotaka Hao, Kazuma Ohyama, Masamichi Nogi, Akira Suda, Shintaro Kasahara, Koichi Sato, Sadamitsu Ichijo, Hiroaki Shimokawa

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Abstract

From August 26th to 30th, the 2017 Annual Congress of the European Society of Cardiology (ESC 2017) was held in Barcelona, Spain. Despite the terrorism tradegy just before the ESC congress, the congress attracted many medical professionals from all over the world to discuss the recent topics in cardiovascular medicine in more than 500 sessions, including COMPASS (Cardiovascular OutcoMes for People using Anticoagulation StrategieS Trial), CANTOS (Canakinumab Anti-Inflammatory Thrombosis Outcomes Study), and ORION (which assessed the effect of a novel siRNA inhibitor to PCSK9 on reductions in low-density lipoprotein cholesterol). Japanese cardiologists and the Japanese Circulation Society greatly contributed to the congress. This report briefly introduces some late-breaking registry results, late-breaking clinical trials, and ESC Guidelines from the ESC 2017 Congress.

Original languageEnglish
Pages (from-to)1758-1763
Number of pages6
JournalCirculation Journal
Volume81
Issue number12
DOIs
Publication statusPublished - 2017

Keywords

  • Cardiology
  • European Society of Cardiology

Fingerprint

Dive into the research topics of 'European society of cardiology (ESC) annual congress report from Barcelona 2017'. Together they form a unique fingerprint.

Cite this